The neuroendocrine tumors market is witnessing robust expansion driven by increasing prevalence of rare cancers and advancements in targeted therapies. Industry size is growing steadily as new diagnostic tools and therapeutic options enter the landscape, reshaping market dynamics globally.Market Size and Overview The Global Neuroendocrine Tumors Market is estimated to be valued at USD 5.11...